Chase Knickerbocker
Stock Analyst at Craig-Hallum
(3.67)
# 834
Out of 4,734 analysts
32
Total ratings
46.88%
Success rate
9.99%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $14.31 | +46.75% | 2 | Jan 17, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $5 → $6 | $4.09 | +46.70% | 2 | Jan 17, 2025 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $15 → $18 | $14.41 | +24.91% | 4 | Jan 8, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $3.28 | +265.85% | 2 | Nov 14, 2024 | |
| PYPD PolyPid | Initiates: Buy | $10 | $3.30 | +203.03% | 1 | Nov 4, 2024 | |
| INDV Indivior | Maintains: Buy | $20 → $16 | $11.65 | +37.34% | 3 | Oct 11, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $65 | $33.85 | +92.02% | 3 | Oct 4, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $17 → $15 | $5.54 | +170.76% | 4 | Aug 14, 2024 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $14 → $10 | $3.66 | +173.22% | 3 | Aug 9, 2024 | |
| MDXG MiMedx Group | Maintains: Buy | $14 → $12 | $9.12 | +31.58% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $6.37 | +56.99% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $7.75 | +196.77% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.52 | +130.77% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $6.96 | +201.72% | 1 | Mar 13, 2023 |
Delcath Systems
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $14.31
Upside: +46.75%
KORU Medical Systems
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $4.09
Upside: +46.70%
Eton Pharmaceuticals
Jan 8, 2025
Maintains: Buy
Price Target: $15 → $18
Current: $14.41
Upside: +24.91%
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $3.28
Upside: +265.85%
PolyPid
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $3.30
Upside: +203.03%
Indivior
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $11.65
Upside: +37.34%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $33.85
Upside: +92.02%
Fennec Pharmaceuticals
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $5.54
Upside: +170.76%
Ironwood Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $14 → $10
Current: $3.66
Upside: +173.22%
MiMedx Group
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $9.12
Upside: +31.58%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $6.37
Upside: +56.99%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $7.75
Upside: +196.77%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.52
Upside: +130.77%
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $6.96
Upside: +201.72%